What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos

1

Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers

2

Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge

3

Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more
Close

Yeast Cells May Revolutionize Genetic Therapies

May 11, 2013, 11:15 AM
Yeast

What's the Latest Development?

For many, migraines are on the short list of conditions that can strike seemingly without provocation and be completely debilitating. But now, a pharmaceutical company in the state of Washington hopes that a new antibody injection can block a specific protein known to cause migraines. "The company, called Alder Biopharmaceuticals, is testing the efficacy of the drug in a clinical study of 160 patients, each of whom has between four and 14 migraines per month; Alder expects the results of the study to be in this fall." The production of the antibody is unique in that the company uses yeast cultures to grow it, rather than mammalian cells.

What's the Big Idea?

When it comes to creating new genetic therapies, the use of yeast to grow antibodies represents what could be a substantial medical breakthrough. While a typical crop of antibodies takes 12 months to grow in mammalian cells, the same amount of medicine can be grown in 5 weeks using yeast cells as incubators. "Alder [Biopharmaceuticals] also says that producing antibodies in yeast will also be cheaper compared to producing them in mammalian cells, which grow more slowly than yeast and require more costly culturing conditions." That could mean more innovative therapies for less cost to patients. 

Photo credit: Shutterstock.com

Read it at MIT Technology Review

 

Yeast Cells May Revolutioni...

Newsletter: Share: